{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:14:38Z","timestamp":1777652078965,"version":"3.51.4"},"reference-count":259,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Institute of Nutrition and Food Safety (INSA) Maria de Maeztu Unit of Excellence grant","award":["CEX2021-001234-M"],"award-info":[{"award-number":["CEX2021-001234-M"]}]},{"name":"Institute of Nutrition and Food Safety (INSA) Maria de Maeztu Unit of Excellence grant","award":["PREDOCS-UB 2022"],"award-info":[{"award-number":["PREDOCS-UB 2022"]}]},{"name":"UE","award":["CEX2021-001234-M"],"award-info":[{"award-number":["CEX2021-001234-M"]}]},{"name":"UE","award":["PREDOCS-UB 2022"],"award-info":[{"award-number":["PREDOCS-UB 2022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Celiac disease (CeD) is a chronic autoimmune enteropathy triggered by dietary gluten in genetically predisposed individuals. Along with other disorders such as non-celiac gluten\/wheat sensitivity and gluten allergy, adherence to a strict gluten-free diet (GFD) is required as the only effective treatment for CeD. To this end, and partially due to the burdensome nature and limited efficacy in some patients of a GFD, significant research into alternative therapies has been catalyzed. This review gives a perspective on current and emerging treatment strategies targeting different aspects of CeD pathogenesis. These include gluten-degrading enzymes (e.g., AN-PEP, Latiglutenase, Zamaglutenase), gluten-sequestering agents (e.g., AGY-010, BL-7010), modulators of intestinal permeability (e.g., Larazotide acetate, IMU-856), immune-modulating agents (e.g., ZED1227, AMG 714, EQ102), and strategies for immune tolerization (e.g., TAK-101, KAN-101, Nexvax2). Newer approaches are also targeting probiotics to modulate the gut microbiota (e.g., VSL#3, Lactobacillus plantarum HEAL9), nutraceuticals (e.g., polyphenols, vitamins), or food modifications to remove the gluten from naturally gluten-containing foodstuffs (e.g., gluten transamidation, Gluten Friendly\u2122 technology). Despite encouraging results in preclinical and clinical trials, no treatment has yet been conclusively proven to serve as an effective alternative to the GFD. Continued research is essential to validate efficacy, optimize dosing, and ensure safety in broader patient populations. Here, we provide a comprehensive overview of the therapeutic landscape for CeD, analyze the main strengths and limitations of each treatment and highlight promising directions for future management of CeD, altogether evidencing the urgent need to develop effective alternatives for these patients.<\/jats:p>","DOI":"10.3390\/nu17182960","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T16:27:33Z","timestamp":1757953653000},"page":"2960","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Is There a Future Without Gluten Restrictions for Celiac Patients? Update on Current Treatments"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8370-6396","authenticated-orcid":false,"given":"Marina","family":"Girbal-Gonz\u00e1lez","sequence":"first","affiliation":[{"name":"Physiology Section, Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, University of Barcelona (UB), 08028 Barcelona, Spain"},{"name":"Nutrition and Food Safety Research Institute (INSA-UB), University of Barcelona (UB), 08921 Santa Coloma de Gramenet, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6243-9164","authenticated-orcid":false,"given":"Francisco J.","family":"P\u00e9rez-Cano","sequence":"additional","affiliation":[{"name":"Physiology Section, Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, University of Barcelona (UB), 08028 Barcelona, Spain"},{"name":"Nutrition and Food Safety Research Institute (INSA-UB), University of Barcelona (UB), 08921 Santa Coloma de Gramenet, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gutjnl-2011-301346","article-title":"The Oslo Definitions for Coeliac Disease and Related Terms","volume":"62","author":"Ludvigsson","year":"2013","journal-title":"Gut"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/2050640619844125","article-title":"European Society for the Study of Coeliac Disease (ESsCD) Guideline for Coeliac Disease and Other Gluten-Related Disorders","volume":"7","author":"Volta","year":"2019","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/jgh.13703","article-title":"What Is Gluten?","volume":"32","author":"Biesiekierski","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"srep45092","DOI":"10.1038\/srep45092","article-title":"Quantitation of the Immunodominant 33-Mer Peptide from \u03b1-Gliadin in Wheat Flours by Liquid Chromatography Tandem Mass Spectrometry","volume":"7","author":"Schalk","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/S0140-6736(22)00794-2","article-title":"Coeliac Disease","volume":"399","author":"Catassi","year":"2022","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41575-021-00552-z","article-title":"The Global Burden of Coeliac Disease: Opportunities and Challenges","volume":"19","author":"Makharia","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.cgh.2018.11.013","article-title":"Sex Difference in Celiac Disease in Undiagnosed Populations: A Systematic Review and Meta-Analysis","volume":"17","author":"Hujoel","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1053\/j.gastro.2024.07.024","article-title":"Long-Term Cost-Effectiveness of Case Finding and Mass Screening for Celiac Disease in Children","volume":"167","author":"Meijer","year":"2024","journal-title":"Gastroenterology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00394-016-1238-5","article-title":"Celiac Disease: Understanding the Gluten-Free Diet","volume":"56","author":"Vespa","year":"2017","journal-title":"Eur. J. Nutr."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Wei, G., Helmerhorst, E.J., Darwish, G., Blumenkranz, G., and Schuppan, D. (2020). Gluten Degrading Enzymes for Treatment of Celiac Disease. Nutrients, 12.","DOI":"10.3390\/nu12072095"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/gut.2006.111609","article-title":"Efficient Degradation of Gluten by a Prolyl Endoprotease in a Gastrointestinal Model: Implications for Coeliac Disease","volume":"57","author":"Mitea","year":"2008","journal-title":"Gut"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.foodchem.2014.11.053","article-title":"Influence of Dietary Components on Aspergillus Niger Prolyl Endoprotease Mediated Gluten Degradation","volume":"174","author":"Montserrat","year":"2015","journal-title":"Food Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"13100","DOI":"10.1038\/s41598-017-13587-7","article-title":"Randomized Clinical Trial: Effective Gluten Degradation by Aspergillus Niger-Derived Enzyme in a Complex Meal Setting","volume":"7","author":"Holster","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/apt.13266","article-title":"Randomised Clinical Study: Aspergillus Niger-Derived Enzyme Digests Gluten in the Stomach of Healthy Volunteers","volume":"42","author":"Salden","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.3748\/wjg.v19.i35.5837","article-title":"Consumption of Gluten with Gluten-Degrading Enzyme by Celiac Patients: A Pilot-Study","volume":"19","author":"Tack","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3748\/wjg.v30.i11.1545","article-title":"Effect of Aspergillus Niger Prolyl Endopeptidase in Patients with Celiac Disease on a Long-Term Gluten-Free Diet","volume":"30","author":"Stefanolo","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.fct.2019.05.011","article-title":"Prolyl Endopeptidase-Degraded Low Immunoreactive Wheat Flour Attenuates Immune Responses in Caco-2 Intestinal Cells and Gluten-Sensitized BALB\/c Mice","volume":"129","author":"Vijaykrishnaraj","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jcs.2014.02.012","article-title":"Production of Gluten-Free Wheat Starch by Peptidase Treatment","volume":"60","author":"Walter","year":"2014","journal-title":"J. Cereal. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00217-015-2617-5","article-title":"Production of Gluten-Free Beer by Peptidase Treatment","volume":"242","author":"Knorr","year":"2016","journal-title":"Eur. Food Res. Technol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"117027","DOI":"10.1016\/j.foodres.2025.117027","article-title":"Digestion Supplemented with Commercial Proteases: Evaluation of the Fate of Gluten Immunogenic Peptides in Pizza","volume":"220","author":"Camarca","year":"2025","journal-title":"Food Res. Int."},{"key":"ref_21","unstructured":"Tschollar, W., and Mourabit, S. (2025, July 30). Pharmaceutical Compositions Comprising Aminopeptidase and Dipeptidylpeptidase Polypeptides and Uses Thereof 2023. Available online: https:\/\/patents.google.com\/patent\/WO2025067633A1\/en?assignee=AMYRA&oq=AMYRA."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1425982","DOI":"10.3389\/fimmu.2024.1425982","article-title":"Exopeptidase Combination Enhances the Degradation of Isotopically Labelled Gluten Immunogenic Peptides in Humans","volume":"15","author":"Mourabit","year":"2024","journal-title":"Front. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e6313","DOI":"10.1371\/journal.pone.0006313","article-title":"A Food-Grade Enzyme Preparation with Modest Gluten Detoxification Properties","volume":"4","author":"Ehren","year":"2009","journal-title":"PLoS ONE"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.foodchem.2015.10.089","article-title":"The Potential of Papain and Alcalase Enzymes and Process Optimizations to Reduce Allergenic Gliadins in Wheat Flour","volume":"196","author":"Li","year":"2016","journal-title":"Food Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e24455","DOI":"10.1371\/journal.pone.0024455","article-title":"Identification of Rothia Bacteria as Gluten-Degrading Natural Colonizers of the Upper Gastro-Intestinal Tract","volume":"6","author":"Zamakhchari","year":"2011","journal-title":"PLoS ONE"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2021.03.019","article-title":"Gluten Degradation, Pharmacokinetics, Safety, and Tolerability of TAK-062, an Engineered Enzyme to Treat Celiac Disease","volume":"161","author":"Pultz","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1021\/jacs.5b08325","article-title":"Engineering of Kuma030: A Gliadin Peptidase That Rapidly Degrades Immunogenic Gliadin Peptides in Gastric Conditions","volume":"137","author":"Wolf","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"ref_28","unstructured":"National Library of Medicine (U.S.) (2025, July 07). A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet, Available online: https:\/\/www.clinicaltrials.gov\/study\/NCT05353985."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Liu, Y.Y., Lee, C.C., Hsu, J.H., Leu, W.M., and Meng, M. (2021). Efficient Hydrolysis of Gluten-Derived Celiac Disease-Triggering Immunogenic Peptides by a Bacterial Serine Protease from Burkholderia Gladioli. Biomolecules, 11.","DOI":"10.3390\/biom11030451"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"13147","DOI":"10.1038\/s41598-019-48299-7","article-title":"E40, a Novel Microbial Protease Efficiently Detoxifying Gluten Proteins, for the Dietary Management of Gluten Intolerance","volume":"9","author":"Cavaletti","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/bit.20643","article-title":"Fermentation, Purification, Formulation, and Pharmacological Evaluation of a Prolyl Endopeptidase from Myxococcus Xanthus: Implications for Celiac Sprue Therapy","volume":"92","author":"Gass","year":"2005","journal-title":"Biotechnol. Bioeng."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1124\/jpet.106.104315","article-title":"Effect of Barley Endoprotease EP-B2 on Gluten Digestion in the Intact Rat","volume":"318","author":"Gass","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0968-0896(98)00145-X","article-title":"The Specificity of Prolyl Endopeptidase from Flavobacterium Meningoseptum: Mapping the S H Subsites by Positional Scanning via Acyl Transfer","volume":"6","author":"Bordusa","year":"1998","journal-title":"Bioorganic Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.chembiol.2006.04.009","article-title":"Rational Design of Combination Enzyme Therapy for Celiac Sprue","volume":"13","author":"Siegel","year":"2006","journal-title":"Chem. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.1021\/acs.jafc.9b00569","article-title":"Phosphorylation and Enzymatic Hydrolysis with Alcalase and Papain Effectively Reduce Allergic Reactions to Gliadins in Normal Mice","volume":"67","author":"Xue","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1038\/s41467-022-32215-1","article-title":"Molecular and in Vivo Studies of a Glutamate-Class Prolyl-Endopeptidase for Coeliac Disease Therapy","volume":"13","author":"Mendes","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"30980","DOI":"10.1038\/srep30980","article-title":"Addressing Proteolytic Efficiency in Enzymatic Degradation Therapy for Celiac Disease","volume":"6","author":"Rey","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00726-023-03333-x","article-title":"Bromelain and Ficin Proteolytic Effects on Gliadin Cytotoxicity and Expression of Genes Involved in Cell-Tight Junctions in Caco-2 Cells","volume":"55","author":"Vaziri","year":"2023","journal-title":"Amino Acids"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.foodchem.2011.06.031","article-title":"Effect of Actinidin from Kiwifruit (Actinidia Deliciosa Cv. Hayward) on the Digestion of Food Proteins Determined in the Growing Rat","volume":"129","author":"Rutherfurd","year":"2011","journal-title":"Food Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"128239","DOI":"10.1016\/j.foodchem.2020.128239","article-title":"The Kiwifruit Enzyme Actinidin Enhances the Hydrolysis of Gluten Proteins during Simulated Gastrointestinal Digestion","volume":"341","author":"Jayawardana","year":"2021","journal-title":"Food Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"111560","DOI":"10.1016\/j.foodres.2022.111560","article-title":"Actinidin Reduces Gluten-Derived Immunogenic Peptides Reaching the Small Intestine in an in Vitro Semi-Dynamic Gastrointestinal Tract Digestion Model","volume":"159","author":"Jayawardana","year":"2022","journal-title":"Food Res. Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.foodchem.2014.08.030","article-title":"Reduction of Toxic Gliadin Content of Wholegrain Bread by the Enzyme Caricain","volume":"170","author":"Buddrick","year":"2015","journal-title":"Food Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biocel.2015.03.001","article-title":"Glutenase and Collagenase Activities of Wheat Cysteine Protease Triticain-\u03b1: Feasibility for Enzymatic Therapy Assays","volume":"62","author":"Savvateeva","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clim.2009.11.001","article-title":"The Effects of ALV003 Pre-Digestion of Gluten on Immune Response and Symptoms in Celiac Disease in Vivo","volume":"134","author":"Anderson","year":"2010","journal-title":"Clin. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Wei, G., Darwish, G., Oppenheim, F.G., Schuppan, D., and Helmerhorst, E.J. (2020). Commensal Bacterium Rothia Aeria Degrades and Detoxifies Gluten via a Highly Effective Subtilisin Enzyme. Nutrients, 12.","DOI":"10.3390\/nu12123724"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00018-006-6317-y","article-title":"Prolyl Endopeptidases","volume":"64","author":"Gass","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_47","unstructured":"Gomis-R\u00fcth, F.X., Del Amo Maestro, L., Dos Mendes Rei, S.I., Eckhard, U., Rodr\u00edguez Banqueri, A., Guevara Puig, T., P\u00e9rez Cano, F., Rodr\u00edguez Lagunas, M.J., Franch Masferrer, \u00c0., and Girbal Gonz\u00e1lez, M. (2025, July 08). Prote\u00edna Degradadora de Gluten y Usos de La Misma 2023. Available online: https:\/\/patents.google.com\/patent\/ES3008845A1\/es."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.foodchem.2016.03.092","article-title":"Effects of Grain Species and Cultivar, Thermal Processing, and Enzymatic Hydrolysis on Gluten Quantitation","volume":"208","author":"Pahlavan","year":"2016","journal-title":"Food Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10620-011-1906-5","article-title":"Safety, Tolerability, and Activity of ALV003: Results from Two Phase 1 Single, Escalating-Dose Clinical Trials","volume":"57","author":"Siegel","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/j.gastro.2014.02.031","article-title":"Glutenase ALV003 Attenuates Gluten-Induced Mucosal Injury in Patients with Celiac Disease","volume":"146","author":"Kaukinen","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1053\/j.gastro.2016.11.004","article-title":"No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients with Symptomatic Celiac Disease","volume":"152","author":"Murray","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1053\/j.gastro.2022.07.071","article-title":"Latiglutenase Protects the Mucosa and Attenuates Symptom Severity in Patients with Celiac Disease Exposed to a Gluten Challenge","volume":"163","author":"Murray","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1021\/jf205319s","article-title":"In-Vitro and in-Vivo Binding Activity of Chicken Egg Yolk Immunoglobulin y (IgY) against Gliadin in Food Matrix","volume":"60","author":"Gujral","year":"2012","journal-title":"J. Agric. Food Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s10620-016-4426-5","article-title":"AGY, a Novel Egg Yolk-Derived Anti-Gliadin Antibody, Is Safe for Patients with Celiac Disease","volume":"62","author":"Sample","year":"2017","journal-title":"Dig. Dis. Sci."},{"key":"ref_55","unstructured":"National Library of Medicine (U.S.) (2025, July 08). A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celiac Disease (AGY-010), Available online: https:\/\/clinicaltrials.gov\/study\/NCT03707730?term=agy-010&rank=1."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1053\/j.gastro.2008.09.016","article-title":"Polymeric Binders Suppress Gliadin-Induced Toxicity in the Intestinal Epithelium","volume":"136","author":"Pinier","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e109972","DOI":"10.1371\/journal.pone.0109972","article-title":"BL-7010 Demonstrates Specific Binding to Gliadin and Reduces Gluten-Associated Pathology in a Chronic Mouse Model of Gliadin Sensitivity","volume":"9","author":"McCarville","year":"2014","journal-title":"PLoS ONE"},{"key":"ref_58","unstructured":"National Library of Medicine (U.S.) (2025, June 18). A Two-Part, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Systemic Exposure of Single Escalating Administrations and Repeated Administration of BL-7010 in Well-Controlled Celiac Patients, Available online: https:\/\/clinicaltrials.gov\/study\/NCT01990885?intr=BL-7010&rank=1."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1053\/j.gastro.2015.02.008","article-title":"Larazotide Acetate for Persistent Symptoms of Celiac Disease despite a Gluten-Free Diet: A Randomized Controlled Trial","volume":"148","author":"Leffler","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2036.2007.03413.x","article-title":"The Safety, Tolerance, Pharmacokinetic and Pharmacodynamic Effects of Single Doses of AT-1001 in Coeliac Disease Subjects: A Proof of Concept Study","volume":"26","author":"Paterson","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/ajg.2012.211","article-title":"A Randomized, Double-Blind Study of Larazotide Acetate to Prevent the Activation of Celiac Disease during Gluten Challenge","volume":"107","author":"Leffler","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/apt.12147","article-title":"Larazotide Acetate in Patients with Coeliac Disease Undergoing a Gluten Challenge: A Randomised Placebo-Controlled Study","volume":"37","author":"Kelly","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_63","unstructured":"National Library of Medicine (U.S.) (2025, July 08). Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms, Available online: https:\/\/clinicaltrials.gov\/study\/NCT03569007?cond=ced%20in%20syndrome&viewType=Table&checkSpell=&rank=2."},{"key":"ref_64","first-page":"150","article-title":"Celiac Disease: Role of the Epithelial Barrier","volume":"3","author":"Schumann","year":"2017","journal-title":"CMGH"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"101782","DOI":"10.1016\/j.clinre.2021.101782","article-title":"Larazotide Acetate for Treatment of Celiac Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"46","author":"Hoilat","year":"2022","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S2468-1253(24)00248-6","article-title":"Safety, Clinical Activity, Pharmacodynamics, and Pharmacokinetics of IMU-856, a SIRT6 Modulator, in Coeliac Disease: A First-in-Human, Randomised, Double-Blind, Placebo-Controlled, Phase 1 Trial","volume":"10","author":"Daveson","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Xu, K., Guo, Y., Ping, L., Qiu, Y., Liu, Q., Li, Z., and Wang, Z. (2020). Protective Effects of SIRT6 Overexpression against DSS-Induced Colitis in Mice. Cells, 9.","DOI":"10.3390\/cells9061513"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2032441","article-title":"A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease","volume":"385","author":"Schuppan","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"B\u00fcchold, C., Hils, M., Gerlach, U., Weber, J., Pelzer, C., Heil, A., Aeschlimann, D., and Pasternack, R. (2022). Features of ZED1227: The First-in-Class Tissue Transglutaminase Inhibitor Undergoing Clinical Evaluation for the Treatment of Celiac Disease. Cells, 11.","DOI":"10.3390\/cells11101667"},{"key":"ref_70","unstructured":"National Library of Medicine (U.S.) (2025, July 09). Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to Evaluate the Interaction Between GSK3915393 and Grapefruit Juice and Itraconazole, Available online: https:\/\/clinicaltrials.gov\/study\/NCT04604795?cond=%22Celiac%20disease%22&rank=9."},{"key":"ref_71","unstructured":"National Library of Medicine (U.S.) (2025, July 09). A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants with Idiopathic Pulmonary Fibrosis (IPF), Available online: https:\/\/clinicaltrials.gov\/study\/NCT06317285?term=Labrador%20Lung&viewType=Table&rank=10."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41586-020-2003-8","article-title":"IL-15, Gluten and HLA-DQ8 Drive Tissue Destruction in Coeliac Disease","volume":"578","author":"Abadie","year":"2020","journal-title":"Nature"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3389\/fimmu.2020.01374","article-title":"Coeliac Disease Pathogenesis: The Uncertainties of a Well-Known Immune Mediated Disorder","volume":"11","author":"Dunne","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2468-1253(19)30264-X","article-title":"Safety and Efficacy of AMG 714 in Adults with Coeliac Disease Exposed to Gluten Challenge: A Phase 2a, Randomised, Double-Blind, Placebo-Controlled Study","volume":"4","author":"Scheinin","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S2468-1253(19)30265-1","article-title":"Safety and Efficacy of AMG 714 in Patients with Type 2 Refractory Coeliac Disease: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study","volume":"4","author":"Cellier","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_76","unstructured":"National Library of Medicine (U.S.) (2025, July 09). PRV-015 in Gluten-Free Diet Non-Responsive Celiac Disease (PROACTIVE), Available online: https:\/\/clinicaltrials.gov\/study\/NCT04424927."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/19420862.2017.1332553","article-title":"Discovery and Characterization of a Novel Humanized Anti-IL-15 Antibody and Its Relevance for the Treatment of Refractory Celiac Disease and Eosinophilic Esophagitis","volume":"9","author":"Vicari","year":"2017","journal-title":"mAbs"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/imr.12191","article-title":"IL-15: A Central Regulator of Celiac Disease Immunopathology","volume":"260","author":"Abadie","year":"2014","journal-title":"Immunol. Rev."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/apt.12859","article-title":"Systematic Review: The Association between Eosinophilic Oesophagitis and Coeliac Disease","volume":"40","author":"Lucendo","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_80","unstructured":"National Library of Medicine (U.S.) (2025, July 10). Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects with Celiac Disease and Eosinophilic Esophagitis, Available online: https:\/\/clinicaltrials.gov\/study\/NCT04593251?intr=CALY-002&rank=1."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1499397","DOI":"10.3389\/fimmu.2025.1499397","article-title":"Modeling Human Natural Killer Cell Development and Drug Response in a Microfluidic Bone Marrow Model","volume":"16","author":"Koenig","year":"2025","journal-title":"Front. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"S-730","DOI":"10.1016\/S0016-5085(24)02155-3","article-title":"Su1326 Developing TEV-53408 for the Treatment of Celiac Disease: Summary of Preliminary Results from the First in Human Phase 1 Study in Healthy Volunteers","volume":"166","author":"Schnir","year":"2024","journal-title":"Gastroenterology"},{"key":"ref_83","unstructured":"National Library of Medicine (U.S.) (2025, July 10). A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults with Celiac Disease ClinicalTrials.Gov ID NCT06807463, Available online: https:\/\/clinicaltrials.gov\/study\/NCT06807463."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4049\/jimmunol.210.Supp.243.19","article-title":"\u0393c Receptor Antagonist, EQ102, Prevents the NK and T Cell-Mediated Responses Driven by IL-15 and IL-21","volume":"210","author":"Tiet","year":"2023","journal-title":"J. Immunol."},{"key":"ref_85","unstructured":"(2022, July 10). Equillium Equillium Announces Initiation of Phase 1 Study of EQ102, A First-in-Class Multi-Cytokine Inhibitor of IL-15 and IL-21 Targeting Celiac Disease. Available online: https:\/\/www.equilliumbio.com\/investors\/press-releases\/news-details\/2022\/Equillium-Announces-Initiation-of-Phase-1-study-of-EQ102-A-First-in-Class-Multi-Cytokine-Inhibitor-of-IL-15-and-IL-21-Targeting-Celiac-Disease\/default.aspx."},{"key":"ref_86","unstructured":"(2022, July 10). Australian New Zealand Clinical Trials Registry a Randomized, Double-Blind, Placebo-Controlled Phase I Study to Assess the Safety and Tolerability of Subcutaneous EQ102 Administered in a Single and Multiple Ascending Dose Schedule. Available online: https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=384358."},{"key":"ref_87","unstructured":"National Library of Medicine (U.S.) (2022, July 10). Study of EQ101 in Adult Subjects with Moderate to Severe Alopecia Areata, Available online: https:\/\/clinicaltrials.gov\/study\/NCT05589610?term=EQ101&rank=1."},{"key":"ref_88","unstructured":"(2025, July 10). Equillium Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease. Available online: https:\/\/www.equilliumbio.com\/investors\/press-releases\/news-details\/2023\/Equillium-Announces-Update-on-Multi-Cytokine-Inhibitors-EQ101--EQ102-in-Development-for-Alopecia-Areata-and-Celiac-Disease\/default.aspx."},{"key":"ref_89","unstructured":"(2025, July 11). Equillium Equillium Announces Preclinical Data from New Orally Deliverable Multi-Cytokine Inhibitor in Presentation at the 18th Annual Peptide Therapeutics Symposium. Available online: https:\/\/www.equilliumbio.com\/investors\/press-releases\/news-details\/2023\/Equillium-Announces-Preclinical-Data-from-New-Orally-Deliverable-Multi-Cytokine-Inhibitor-in-Presentation-at-the-18th-Annual-Peptide-Therapeutics-Symposium\/default.aspx."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Rotondi Aufiero, V., Iacomino, G., De Chiara, G., Picariello, E., Iaquinto, G., Troncone, R., and Mazzarella, G. (2025). Neutralizing IL-15 Inhibits Tissue-Damaging Immune Response in Ex Vivo Cultured Untreated Celiac Intestinal Mucosa. Cells, 14.","DOI":"10.3390\/cells14030234"},{"key":"ref_91","unstructured":"National Library of Medicine (U.S.) (2025, July 09). A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients with Celiac Disease, Available online: https:\/\/clinicaltrials.gov\/study\/NCT02637141?cond=celiac&intr=prv-015&rank=2&tab=results."},{"key":"ref_92","unstructured":"National Library of Medicine (U.S.) (2022, July 10). A Phase II Study of CCX282-B in Patients with Celiac Disease, Available online: https:\/\/clinicaltrials.gov\/study\/NCT00540657?term=NCT00540657&rank=1."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1124\/jpet.110.169714","article-title":"Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease","volume":"335","author":"Walters","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_94","unstructured":"National Library of Medicine (U.S.) (2022, July 11). PTG-100 for Patients with Celiac Disease, Available online: https:\/\/www.clinicaltrials.gov\/study\/NCT04524221."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1053\/j.gastro.2021.08.045","article-title":"PTG-100, an Oral A4\u03b27 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis","volume":"161","author":"Sandborn","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.molimm.2009.10.036","article-title":"Design, Synthesis and Evaluation of High-Affinity Binders for the Celiac Disease Associated HLA-DQ2 Molecule","volume":"47","author":"Kapoerchan","year":"2010","journal-title":"Mol. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.bmc.2007.10.091","article-title":"Design of Azidoproline Containing Gluten Peptides to Suppress CD4+ T-Cell Responses Associated with Celiac Disease","volume":"16","author":"Kapoerchan","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.cgh.2024.05.022","article-title":"Enduring Clinical Remission in Refractory Celiac Disease Type II with Tofacitinib: An Open-Label Clinical Study","volume":"22","author":"Dieckman","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s40265-023-01928-y","article-title":"Ritlecitinib: First Approval","volume":"83","author":"Blair","year":"2023","journal-title":"Drugs"},{"key":"ref_100","unstructured":"National Library of Medicine (U.S.) (2025, July 11). Double Blind, Placebo-Controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission, Available online: https:\/\/clinicaltrials.gov\/study\/NCT05636293?cond=celiac%20disease&intr=ritlecitinib&rank=1."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00403-024-03784-6","article-title":"Ritlecitinib, a JAK3 \/TEC Inhibitor, Modulates the Markers of Celiac Autoimmunity in Alopecia Areata and Vitiligo Patients","volume":"317","author":"Choung","year":"2025","journal-title":"Arch. Dermatol. Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/MPG.0000000000002736","article-title":"Celiac Disease in Patients with Cystic Fibrosis on Ivacaftor: A Case Series","volume":"71","author":"Hjelm","year":"2020","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1513\/AnnalsATS.201510-669LE","article-title":"Resolution of Intestinal Histopathology Changes in Cystic Fibrosis after Treatment with Ivacaftor","volume":"13","author":"Safe","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e100101","DOI":"10.15252\/embj.2018100101","article-title":"A Pathogenic Role for Cystic Fibrosis Transmembrane Conductance Regulator in Celiac Disease","volume":"38","author":"Villella","year":"2019","journal-title":"EMBO J."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e1900989","DOI":"10.1002\/mnfr.201900989","article-title":"Circulating Dendritic Cells from Celiac Disease Patients Display a Gut-Homing Profile and Are Differentially Modulated by Different Gliadin-Derived Peptides","volume":"64","author":"Garrote","year":"2020","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.humpath.2008.10.014","article-title":"Increased Expression of Mucosal Addressin Cell Adhesion Molecule 1 in the Duodenum of Patients with Active Celiac Disease Is Associated with Depletion of Integrin A4\u03b27-Positive T Cells in Blood","volume":"40","author":"Rovedatti","year":"2009","journal-title":"Hum. Pathol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.14309\/ajg.0000000000000310","article-title":"A Clinician\u2019s Guide to Celiac Disease HLA Genetics","volume":"114","author":"Brown","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Lei, H., Crawford, M.S., and McCole, D.F. (2021). Jak-Stat Pathway Regulation of Intestinal Permeability: Pathogenic Roles and Therapeutic Opportunities in Inflammatory Bowel Disease. Pharmaceuticals, 14.","DOI":"10.3390\/ph14090840"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s10875-012-9849-y","article-title":"Tofacitinib, a Janus Kinase Inhibitor Demonstrates Efficacy in an IL-15 Transgenic Mouse Model That Recapitulates Pathologic Manifestations of Celiac Disease","volume":"33","author":"Yokoyama","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/L20-0497","article-title":"Celiac Disease Remission with Tofacitinib: A Case Report","volume":"173","author":"Wauters","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_111","first-page":"1","article-title":"Significant Improvement of Dermatitis Herpetiformis with Tofacitinib","volume":"27","author":"Kahn","year":"2021","journal-title":"Dermatol. Online J."},{"key":"ref_112","first-page":"374","article-title":"Tofacitinib for Celiac Disease and Microscopic Colitis: Killing Two Birds with One Stone","volume":"86","author":"Lenfant","year":"2023","journal-title":"Acta Gastroenterol. Belg."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13052-019-0627-9","article-title":"The Gliadin-CFTR Connection: New Perspectives for the Treatment of Celiac Disease","volume":"45","author":"Maiuri","year":"2019","journal-title":"Ital. J. Pediatr."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ebiom.2017.11.018","article-title":"Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study","volume":"26","author":"Daveson","year":"2017","journal-title":"EBioMedicine"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S2468-1253(17)30110-3","article-title":"Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Coeliac Disease: Two Randomised, Double-Blind, Placebo-Controlled Phase 1 Studies","volume":"2","author":"Goel","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/apt.15435","article-title":"Randomised Clinical Trial: A Placebo-Controlled Study of Subcutaneous or Intradermal NEXVAX2, an Investigational Immunomodulatory Peptide Therapy for Coeliac Disease","volume":"50","author":"Truitt","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S2468-1253(22)00428-9","article-title":"Efficacy and Safety of Gluten Peptide-Based Antigen-Specific Immunotherapy (Nexvax2) in Adults with Coeliac Disease after Bolus Exposure to Gluten (RESET CeD): An Interim Analysis of a Terminated Randomised, Double-Blind, Placebo-Controlled Phase 2 Study","volume":"8","author":"Daveson","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_118","unstructured":"Tye-Din, J. (2019). Discontinuation of the Nexvax2 Phase 2 Trial. Aust. Coeliac, 21."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1053\/j.gastro.2021.03.014","article-title":"TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study","volume":"161","author":"Kelly","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_120","unstructured":"National Library of Medicine (U.S.) (2025, July 11). Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants with Celiac Disease on a Gluten-Free Diet, Available online: https:\/\/clinicaltrials.gov\/study\/NCT04530123?intr=TAK%20101&rank=1."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S2468-1253(23)00107-3","article-title":"Safety and Tolerability of KAN-101, a Liver-Targeted Immune Tolerance Therapy, in Patients with Coeliac Disease (ACeD): A Phase 1 Trial","volume":"8","author":"Murray","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_122","unstructured":"National Library of Medicine (U.S.) (2025, July 14). A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (AceD-It), Available online: https:\/\/www.clinicaltrials.gov\/study\/NCT05574010."},{"key":"ref_123","unstructured":"National Library of Medicine (U.S.) (2025, July 14). A Study of Efficacy, Safety, and Tolerability of KAN-101 in People with Celiac Disease (SynCeD), Available online: https:\/\/clinicaltrials.gov\/study\/NCT06001177."},{"key":"ref_124","unstructured":"(2025, July 14). Topas Therapeutics Topas Therapeutics\u2019 TPM502 Achieves Gluten-Specific Tolerance Induction, Positive Safety Profile in Phase 2a Trial in Celiac Disease Patients. Available online: https:\/\/topas-therapeutics.com\/topas-therapeutics-tpm502-achieves-gluten-specific-tolerance-induction-positive-safety-profile-in-phase-2a-trial-in-celiac-disease-patients\/."},{"key":"ref_125","unstructured":"National Library of Medicine (U.S.) (2025, July 14). A Study to Assess the Safety of TPM502 in Adults with Celiac Disease, Available online: https:\/\/clinicaltrials.gov\/study\/NCT05660109?term=TPM502&rank=1."},{"key":"ref_126","first-page":"37","article-title":"A Randomized, Double-Blind, Placebo-Controlled, Phase 1\/2a Trial Protocol to Assess the Safety and Efficacy of TAK-101 Administered by Microneedles in Patients with Celiac Disease","volume":"8","year":"2022","journal-title":"Princ. Pract. Clin. Res. J."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.3390\/nu7085314","article-title":"Intestinal Microbiota and Celiac Disease: Cause, Consequence or Co-Evolution?","volume":"7","author":"Cenit","year":"2015","journal-title":"Nutrients"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nri3430","article-title":"Role of the Gut Microbiota in Immunity and Inflammatory Disease","volume":"13","author":"Kamada","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"e17996","DOI":"10.1371\/journal.pone.0017996","article-title":"Depletion of Murine Intestinal Microbiota: Effects on Gut Mucosa and Epithelial Gene Expression","volume":"6","author":"Reikvam","year":"2011","journal-title":"PLoS ONE"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/jcp.2008.061366","article-title":"Specific Duodenal and Faecal Bacterial Groups Associated with Paediatric Coeliac Disease","volume":"62","author":"Collado","year":"2009","journal-title":"J. Clin. Pathol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/1471-2180-8-232","article-title":"Imbalances in Faecal and Duodenal Bifidobacterium Species Composition in Active and Non-Active Coeliac Disease","volume":"8","author":"Collado","year":"2008","journal-title":"BMC Microbiol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2180-11-219","article-title":"Duodenal and Faecal Microbiota of Celiac Children: Molecular, Phenotype and Metabolome Characterization","volume":"11","author":"Ndagijimana","year":"2011","journal-title":"BMC Microbiol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1139\/cjm-2014-0472","article-title":"Decrease in Lactobacilli in the Intestinal Microbiota of Celiac Children with a Gluten-Free Diet, And Selection of Potentially Probiotic Strains","volume":"61","author":"Pisarello","year":"2014","journal-title":"Can J. Microbiol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/ajg.2014.355","article-title":"Altered Duodenal Microbiota Composition in Celiac Disease Patients Suffering from Persistent Symptoms on a Long-Term Gluten-Free Diet","volume":"109","author":"Wacklin","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/MIB.0b013e31828029a9","article-title":"The Duodenal Microbiota Composition of Adult Celiac Disease Patients Is Associated with the Clinical Manifestation of the Disease","volume":"19","author":"Wacklin","year":"2013","journal-title":"Inflamm. Bowel. Dis."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","article-title":"The International Scientific Association of Probiotics and Prebiotics (ISAPP) Consensus Statement on the Definition and Scope of Postbiotics","volume":"18","author":"Salminen","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MCG.0b013e31827759ac","article-title":"Exploratory, Randomized, Double-Blind, Placebo-Controlled Study on the Effects of Bifidobacterium Infantis Natren Life Start Strain Super Strain in Active Celiac Disease","volume":"47","author":"Smecuol","year":"2013","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3920\/BM2020.0016","article-title":"Effect of Bifidobacterium Infantis NLS Super Strain in Symptomatic Coeliac Disease Patients on Long-Term Gluten-Free Diet\u2014An Exploratory Study","volume":"11","author":"Smecuol","year":"2020","journal-title":"Benef. Microbes"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1007\/s10620-015-3769-7","article-title":"Administration of Bifidobacterium Breve Decreases the Production of TNF-\u03b1 in Children with Celiac Disease","volume":"60","author":"Klemenak","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Quagliariello, A., Aloisio, I., Cionci, N.B., Luiselli, D., D\u2019Auria, G., Martinez-Priego, L., P\u00e9rez-Villarroya, D., Langerholc, T., Primec, M., and Mi\u010deti\u0107-Turk, D. (2016). Effect of Bifidobacterium Breve on the Intestinal Microbiota of Coeliac Children on a Gluten Free Diet: A Pilot Study. Nutrients, 8.","DOI":"10.3390\/nu8100660"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.clnu.2018.06.931","article-title":"Clinical Intervention Using Bifidobacterium Strains in Celiac Disease Children Reveals Novel Microbial Modulators of TNF-\u03b1 and Short-Chain Fatty Acids","volume":"38","author":"Primec","year":"2019","journal-title":"Clin. Nutr."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e30744","DOI":"10.1371\/journal.pone.0030744","article-title":"Bifidobacterium Longum CECT 7347 Modulates Immune Responses in a Gliadin-Induced Enteropathy Animal Model","volume":"7","author":"Laparra","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1017\/S0007114513001098","article-title":"Oral Administration of Bifidobacterium Longum CECT 7347 Ameliorates Gliadin-Induced Alterations in Liver Iron Mobilisation","volume":"110","author":"Laparra","year":"2013","journal-title":"Br. J. Nutr."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1017\/S0007114514000609","article-title":"Double-Blind, Randomised, Placebo-Controlled Intervention Trial to Evaluate the Effects of Bifidobacterium Longum CECT 7347 in Children with Newly Diagnosed Coeliac Disease","volume":"112","author":"Olivares","year":"2014","journal-title":"Br. J. Nutr."},{"key":"ref_145","first-page":"187","article-title":"Pilot Study on Non-Celiac Gluten Sensitivity: Effects of Bifidobacterium Longum Es1 Co-Administered with a Gluten-Free Diet","volume":"66","author":"Bergomas","year":"2020","journal-title":"Minerva Gastroenterol. Dietol."},{"key":"ref_146","unstructured":"National Library of Medicine (2025, July 15). Efficacy of Probiotic ES1 for the Treatment of Non-Celiac Gluten Sensitivity, Available online: https:\/\/clinicaltrials.gov\/study\/NCT02810301."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Naghibi, M., Pont-Beltran, A., Lamelas, A., Llobregat, L., Martinez-Blanch, J.F., Rojas, A., \u00c1lvarez, B., L\u00f3pez Plaza, B., Arcos Castellanos, L., and Chenoll, E. (2024). Effect of Postbiotic Bifidobacterium Longum CECT 7347 on Gastrointestinal Symptoms, Serum Biochemistry, and Intestinal Microbiota in Healthy Adults: A Randomised, Parallel, Double-Blind, Placebo-Controlled Pilot Study. Nutrients, 16.","DOI":"10.3390\/nu16223952"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2338322","DOI":"10.1080\/19490976.2024.2338322","article-title":"A Randomized Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Live Bifidobacterium Longum CECT 7347 (ES1) and Heat-Treated Bifidobacterium Longum CECT 7347 (HT-ES1) in Participants with Diarrhea-Predominant Irritable Bowel Syndrome","volume":"16","author":"Srivastava","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/ajg.2014.48","article-title":"Novel Role of the Serine Protease Inhibitor Elafin in Gluten-Related Disorders","volume":"109","author":"Galipeau","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"e01323-17","DOI":"10.1128\/AEM.01323-17","article-title":"A Commensal Bifidobacterium Longum Strain Prevents Gluten-Related Immunopathology in Mice through Expression of a Serine Protease Inhibitor","volume":"83","author":"McCarville","year":"2017","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_151","unstructured":"National Library of Medicine (U.S.) (2025, July 15). Probiotic BL NCC 2705 and Gluten Sensitivity, Available online: https:\/\/clinicaltrials.gov\/study\/NCT03775499?intr=BL%20NCC&rank=1."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2249.2008.03635.x","article-title":"Live Probiotic Bifidobacterium Lactis Bacteria Inhibit the Toxic Effects Induced by Wheat Gliadin in Epithelial Cell Culture","volume":"152","author":"Lindfors","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"680771","DOI":"10.3389\/fnut.2021.680771","article-title":"Effects of Probiotic Bacteria Lactobacillaceae on the Gut Microbiota in Children with Celiac Disease Autoimmunity: A Placebo-Controlled and Randomized Clinical Trial","volume":"8","author":"Oscarsson","year":"2021","journal-title":"Front. Nutr."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"H\u00e5kansson, \u00c5., Aronsson, C.A., Brundin, C., Oscarsson, E., Molin, G., and Agardh, D. (2019). Effects of Lactobacillus Plantarum and Lactobacillus Paracasei on the Peripheral Immune Response in Children with Celiac Disease Autoimmunity: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients, 11.","DOI":"10.3390\/nu11081925"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1183963","DOI":"10.3389\/fnut.2023.1183963","article-title":"Effects of Lactiplantibacillus Plantarum and Lacticaseibacillus Paracasei Supplementation on the Faecal Metabolome in Children with Coeliac Disease Autoimmunity: A Randomised, Double-Blinded Placebo-Controlled Clinical Trial","volume":"10","author":"Jenickova","year":"2023","journal-title":"Front. Nutr."},{"key":"ref_156","unstructured":"National Library of Medicine (U.S.) (2025, July 15). Prevention Av Autoimmunitet Med Laktobaciller (PAL), Available online: https:\/\/clinicaltrials.gov\/study\/NCT04014660?intr=laktobaciller&rank=1."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/jam.12687","article-title":"Identification and Characterization of Intestinal Lactobacilli Strains Capable of Degrading Immunotoxic Peptides Present in Gluten","volume":"118","author":"Duar","year":"2015","journal-title":"J. Appl. Microbiol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s12602-020-09723-x","article-title":"Probiotic Potential and Gluten Hydrolysis Activity of Lactobacillus Brevis KT16-2","volume":"13","author":"Kunduhoglu","year":"2021","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.imlet.2008.04.006","article-title":"Adjuvant Effect of Lactobacillus Casei in a Mouse Model of Gluten Sensitivity","volume":"119","author":"Maurano","year":"2008","journal-title":"Immunol. Lett."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-3083.2011.02582.x","article-title":"Immunomodulatory Effects of Lactobacillus Casei Administration in a Mouse Model of Gliadin-Sensitive Enteropathy","volume":"74","author":"Stefanile","year":"2011","journal-title":"Scand. J. Immunol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.cyto.2009.08.003","article-title":"Modulation of the Immune Response by Probiotic Strains in a Mouse Model of Gluten Sensitivity","volume":"48","author":"Maurano","year":"2009","journal-title":"Cytokine"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/genomeA.00952-17","article-title":"Draft Genome Sequence of the Gluten-Hydrolyzing Bacterium Bacillus Subtilis GS 188, Isolated from Wheat Sourdough","volume":"5","author":"Rashmi","year":"2017","journal-title":"Genome Announc."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/jam.13517","article-title":"Molecular Characterization of Gluten Hydrolysing Bacillus Sp. and Their Efficacy and Biotherapeutic Potential as Probiotics Using Caco-2 Cell Line","volume":"123","author":"Rashmi","year":"2017","journal-title":"J. Appl. Microbiol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.lwt.2018.01.023","article-title":"Isolation and Characterization of Gluten-Degrading Enterococcus Mundtii and Wickerhamomyces Anomalus, Potential Probiotic Strains from Indigenously Fermented Sourdough (Khamir)","volume":"91","author":"Sakandar","year":"2018","journal-title":"LWT"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41390-023-02960-0","article-title":"Novel Bacteroides Vulgatus Strain Protects against Gluten-Induced Break of Human Celiac Gut Epithelial Homeostasis: A Pre-Clinical Proof-of-Concept Study","volume":"95","author":"Tran","year":"2024","journal-title":"Pediatr. Res."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Martorell, P., Alvarez, B., Llopis, S., Navarro, V., Ortiz, P., Gonzalez, N., Balaguer, F., Rojas, A., Chenoll, E., and Ram\u00f3n, D. (2021). Heat-Treated Bifidobacterium Longum CECT-7347: A Whole-Cell Postbiotic with Antioxidant, Anti-Inflammatory, and Gut-Barrier Protection Properties. Antioxidants, 10.","DOI":"10.3390\/antiox10040536"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"9048574","DOI":"10.1155\/2016\/9048574","article-title":"Probiotics and the Microbiome in Celiac Disease: A Randomised Controlled Trial","volume":"2016","author":"Harnett","year":"2016","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbadis.2005.09.008","article-title":"VSL#3 Probiotic Preparation Has the Capacity to Hydrolyze Gliadin Polypeptides Responsible for Celiac Sprue","volume":"1762","author":"Rizzello","year":"2006","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"E117","DOI":"10.1097\/MCG.0000000000001023","article-title":"Clinical and Microbiological Effect of a Multispecies Probiotic Supplementation in Celiac Patients with Persistent IBS-Type Symptoms: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial","volume":"53","author":"Francavilla","year":"2019","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.dld.2023.04.021","article-title":"Effects of the Supplementation with a Multispecies Probiotic on Clinical and Laboratory Recovery of Children with Newly Diagnosed Celiac Disease: A Randomized, Placebo-Controlled Trial","volume":"55","author":"Lionetti","year":"2023","journal-title":"Dig. Liver Dis."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Ferrari, E., Monzani, R., Saverio, V., Gagliardi, M., Pa\u0144czyszyn, E., Raia, V., Villella, V.R., Bona, G., Pane, M., and Amoruso, A. (2021). Probiotics Supplements Reduce Er Stress and Gut Inflammation Associated with Gliadin Intake in a Mouse Model of Gluten Sensitivity. Nutrients, 13.","DOI":"10.3390\/nu13041221"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/labinvest.2012.13","article-title":"Gluten Induces Coeliac-like Disease in Sensitised Mice Involving IgA, CD71 and Transglutaminase 2 Interactions That Are Prevented by Probiotics","volume":"92","author":"Papista","year":"2012","journal-title":"Lab. Investig."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"e00274","DOI":"10.14309\/ctg.0000000000000274","article-title":"Randomized, Placebo Controlled Trial of Experimental Hookworm Infection for Improving Gluten Tolerance in Celiac Disease","volume":"11","author":"Croese","year":"2020","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"e17366","DOI":"10.1371\/journal.pone.0017366","article-title":"Effect of Hookworm Infection on Wheat Challenge in Celiac Disease\u2014A Randomised Double-Blinded Placebo Controlled Trial","volume":"6","author":"Daveson","year":"2011","journal-title":"PLoS ONE"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"36797","DOI":"10.1038\/srep36797","article-title":"Changes in Duodenal Tissue-Associated Microbiota Following Hookworm Infection and Consecutive Gluten Challenges in Humans with Coeliac Disease","volume":"6","author":"Giacomin","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Feru\u015b, K., Drabi\u0144ska, N., Krupa-Kozak, U., and Jarocka-Cyrta, E. (2018). A Randomized, Placebo-Controlled, Pilot Clinical Trial to Evaluate the Effect of Supplementation with Prebiotic Synergy 1 on Iron Homeostasis in Children and Adolescents with Celiac Disease Treated with a Gluten-Free Diet. Nutrients, 10.","DOI":"10.3390\/nu10111818"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12937-017-0268-z","article-title":"The Effect of Oligofructose-Enriched Inulin Supplementation on Gut Microbiota, Nutritional Status and Gastrointestinal Symptoms in Paediatric Coeliac Disease Patients on a Gluten-Free Diet: Study Protocol for a Pilot Randomized Controlled Trial","volume":"16","year":"2017","journal-title":"Nutr. J."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00726-018-2622-7","article-title":"Plasma Profile and Urine Excretion of Amino Acids in Children with Celiac Disease on Gluten-Free Diet after Oligofructose-Enriched Inulin Intervention: Results of a Randomised Placebo-Controlled Pilot Study","volume":"50","author":"Ciska","year":"2018","journal-title":"Amino Acids"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Drabi\u0144ska, N., Jarocka-Cyrta, E., Markiewicz, L.H., and Krupa-Kozak, U. (2018). The Effect of Oligofructose-Enriched Inulin on Faecal Bacterial Counts and Microbiota-Associated Characteristics in Celiac Disease Children Following a Gluten-Free Diet: Results of a Randomized, Placebo-Controlled Trial. Nutrients, 10.","DOI":"10.3390\/nu10020201"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"e00376-17","DOI":"10.1128\/AEM.00376-17","article-title":"Selected Probiotic Lactobacilli Have the Capacity to Hydrolyze Gluten Peptides during Simulated Gastrointestinal Digestion","volume":"83","author":"Francavilla","year":"2017","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4269\/ajtmh.2007.76.972","article-title":"An Inverse Relationship Between Autoimmune Liver Diseases and Strongyloides Stercoralis Infection","volume":"76","author":"Aoyama","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1111\/j.1572-0241.2003.07660.x","article-title":"Trichuris Suis Seems to Be Safe and Possibly Effective in the Treatment of Inflammatory Bowel Disease","volume":"98","author":"Summers","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3748\/wjg.v16.i6.703","article-title":"Schistosoma Mansoni Proteins Attenuate Gastrointestinal Motility Disturbances during Experimental Colitis in Mice","volume":"16","author":"Ruyssers","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.gastro.2005.01.005","article-title":"Trichuris Suis Therapy for Active Ulcerative Colitis: A Randomized Controlled Trial","volume":"128","author":"Summers","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ana.21067","article-title":"Association between Parasite Infection and Immune Responses in Multiple Sclerosis","volume":"61","author":"Correale","year":"2007","journal-title":"Ann. Neurol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaci.2009.08.006","article-title":"Trichuris Suis Ova Therapy for Allergic Rhinitis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial","volume":"125","author":"Bager","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Drabi\u0144ska, N., Krupa-Kozak, U., and Jarocka-Cyrta, E. (2020). Intestinal Permeability in Children with Celiac Disease after the Administration of Oligofructose-Enriched Inulin into a Gluten-Free Diet\u2014Results of a Randomized, Placebo-Controlled, Pilot Trial. Nutrients, 12.","DOI":"10.3390\/nu12061736"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"385","DOI":"10.15403\/jgld.2014.1121.253.cel","article-title":"Serendipity in Refractory Celiac Disease: Full Recovery of Duodenal Villi and Clinical Symptoms after Fecal Microbiota Transfer","volume":"25","author":"Kassam","year":"2016","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_189","unstructured":"National Library of Medicine (U.S.) (2025, July 16). Safety and Efficacy of Fecal Microbiota Transplantation, Available online: https:\/\/clinicaltrials.gov\/study\/NCT04014413?intr=fecal%20microbiota%20transplantation&page=2&rank=18."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Singh, S., Razak, M.A., Sangam, S.R., Viswanath, B., Begum, P.S., and Rajagopal, S. (2018). The Impact of Functional Food and Nutraceuticals in Health. Therapeutic Foods, Elsevier.","DOI":"10.1016\/B978-0-12-811517-6.00002-7"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2374628","DOI":"10.1080\/21688370.2024.2374628","article-title":"Potential of Nutraceuticals in Celiac Disease","volume":"13","author":"Jahdkaran","year":"2024","journal-title":"Tissue Barriers"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.5740\/jaoacint.19-0133","article-title":"Natural Polyphenols: Chemical Classification, Definition of Classes, Subcategories, and Structures","volume":"102","author":"Singla","year":"2019","journal-title":"J. AOAC Int."},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Van Buiten, C.B., and Elias, R.J. (2021). Gliadin Sequestration as a Novel Therapy for Celiac Disease: A Prospective Application for Polyphenols. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020595"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"e1700879","DOI":"10.1002\/mnfr.201700879","article-title":"Green Tea Polyphenols Mitigate Gliadin-Mediated Inflammation and Permeability in Vitro","volume":"62","author":"Lambert","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ijbiomac.2018.12.224","article-title":"Effects of Tea Polyphenols and Gluten Addition on in Vitro Wheat Starch Digestion Properties","volume":"126","author":"Xie","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"125051","DOI":"10.1016\/j.foodchem.2019.125051","article-title":"A Multi-Spectroscopic Study on the Interaction of Food Polyphenols with a Bioactive Gluten Peptide: From Chemistry to Biological Implications","volume":"299","author":"Dias","year":"2019","journal-title":"Food Chem."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1021\/acs.jafc.6b05371","article-title":"Polyphenol Interactions Mitigate the Immunogenicity and Allergenicity of Gliadins","volume":"65","author":"Lupi","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/jrs.4288","article-title":"Raman Characterization of the Interactions between Gliadins and Anthocyanins","volume":"44","author":"Taddei","year":"2013","journal-title":"J. Raman Spectrosc."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1016\/j.foodchem.2013.05.136","article-title":"Study on the Interaction between Gliadins and a Coumarin as Molecular Model System of the Gliadins-Anthocyanidins Complexes","volume":"141","author":"Tozzi","year":"2013","journal-title":"Food Chem."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"117937","DOI":"10.1016\/j.saa.2019.117937","article-title":"Interaction between Wheat Gliadin and Quercetin under Different PH Conditions Analyzed by Multi-Spectroscopy Methods","volume":"229","author":"Wang","year":"2020","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"9343","DOI":"10.1039\/D4FO03025G","article-title":"Quercetin Ameliorates Celiac-Related Intestinal Inflammation Caused by Wheat Gluten through Modulating Oxidative Stress, Th1\/Th2\/Treg Balance, and Intestinal Microflora Structure","volume":"15","author":"Yu","year":"2024","journal-title":"Food Funct."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"13474","DOI":"10.1021\/acs.jafc.1c03713","article-title":"New-Level Insights into the Effects of Grape Seed Polyphenols on the Intestinal Processing and Transport of a Celiac Disease Immunodominant Peptide","volume":"69","author":"Dias","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"109100","DOI":"10.1016\/j.clim.2022.109100","article-title":"Effect and Mechanism of Peanut Skin Proanthocyanidins on Gliadin-Induced Caco-2 Celiac Disease Model Cells","volume":"245","author":"Wang","year":"2022","journal-title":"Clin. Immunol."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Klus\u00f3czki, \u00c1., Ol\u00e1h, B., Hossz\u00fa, D., Fenyvesi, F., Remenyik, J., Homoki, J., Gy\u00f6ngy\u00f6si, A., B\u00e1cskay, I., and V\u00e1radi, J. (2023). Effectiveness of Anthocyanin-Rich Sour Cherry Extract on Gliadin-Induced Caco-2 Barrier Damage. Nutrients, 15.","DOI":"10.3390\/nu15184022"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s10787-018-0460-6","article-title":"Ex Vivo Immunomodulatory Effect of Ethanolic Extract of Propolis during Celiac Disease: Involvement of Nitric Oxide Pathway","volume":"26","author":"Medjeber","year":"2018","journal-title":"Inflammopharmacology"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"112759","DOI":"10.1016\/j.biopha.2022.112759","article-title":"Evaluating the Effects of a Standardized Polyphenol Mixture Extracted from Poplar-Type Propolis on Healthy and Diseased Human Gut Microbiota","volume":"148","author":"Garzarella","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s10753-020-01383-x","article-title":"Mitigation of Gliadin-Induced Inflammation and Cellular Damage by Curcumin in Human Intestinal Cell Lines","volume":"44","author":"Gupta","year":"2021","journal-title":"Inflammation"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"878186","DOI":"10.3389\/fimmu.2022.878186","article-title":"The Nutritional Intervention of Resveratrol Can Effectively Alleviate the Intestinal Inflammation Associated with Celiac Disease Induced by Wheat Gluten","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejphar.2007.03.051","article-title":"Lycopene, Quercetin and Tyrosol Prevent Macrophage Activation Induced by Gliadin and IFN-\u03b3","volume":"566","author":"Maiuri","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"P\u00e9riz, M., Rodr\u00edguez-Lagunas, M.J., P\u00e9rez-Cano, F.J., Best, I., Pastor-Soplin, S., Castell, M., and Massot-Cladera, M. (2022). Influence of Consumption of Two Peruvian Cocoa Populations on Mucosal and Systemic Immune Response in an Allergic Asthma Rat Model. Nutrients, 14.","DOI":"10.3390\/nu14030410"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.phrs.2012.02.001","article-title":"A Diet Enriched with Cocoa Prevents IgE Synthesis in a Rat Allergy Model","volume":"65","author":"Castellote","year":"2012","journal-title":"Pharmacol. Res."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00394-008-0761-4","article-title":"Neuroprotective Effect of Cocoa Flavonids on in Vitro Oxidative Stress","volume":"48","author":"Lee","year":"2009","journal-title":"Eur. J. Nutr."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1017\/S0007114514003080","article-title":"Impact of Cocoa Polyphenol Extracts on the Immune System and Microbiota in Two Strains of Young Rats","volume":"112","author":"Torres","year":"2014","journal-title":"Br. J. Nutr."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1021\/acs.jafc.8b07248","article-title":"Role of Theobromine in Cocoa\u2019s Metabolic Properties in Healthy Rats","volume":"67","author":"Cambras","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/jn\/nxx056","article-title":"Theobromine Is Responsible for the Effects of Cocoa on the Antibody Immune Status of Rats","volume":"148","author":"Franch","year":"2018","journal-title":"J. Nutr."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.3390\/nu5104159","article-title":"Health Benefits of Methylxanthines in Cacao and Chocolate","volume":"5","author":"Franco","year":"2013","journal-title":"Nutrients"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1017\/S000711451600074X","article-title":"Cocoa and Cocoa Fibre Differentially Modulate IgA and IgM Production at Mucosal Sites","volume":"115","author":"Franch","year":"2016","journal-title":"Br. J. Nutr."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jff.2019.03.039","article-title":"Procyanidin B2 Rich Cocoa Extracts Inhibit Inflammation in Caco-2 Cell Model of in Vitro Celiac Disease by down-Regulating Interferon-Gamma- or Gliadin Peptide 31-43-Induced Transglutaminase-2 and Interleukin-15","volume":"57","author":"Kramer","year":"2019","journal-title":"J. Funct. Foods"},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Raguzzini, A., Poce, G., Consalvi, S., Toti, E., Palmacci, F., Biava, M., and Peluso, I. (2019). Chocolate Consumers and Lymphocyte-to-Monocyte Ratio: A Working Hypothesis from a Preliminary Report of a Pilot Study in Celiac Subjects. Antioxidants, 8.","DOI":"10.3390\/antiox8100440"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1007\/s10067-017-3815-2","article-title":"The Association between the Lymphocyte-Monocyte Ratio and Disease Activity in Rheumatoid Arthritis","volume":"36","author":"Du","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"ref_221","first-page":"149","article-title":"Caracterizaci\u00f3n de La Composici\u00f3n y La Funci\u00f3n de La Microbiota Intestinal En Un Modelo Precl\u00ednico de Celiaqu\u00eda","volume":"6","author":"Eckhard","year":"2025","journal-title":"XVI Workshop Soc. Espa\u00f1ola Microbiota Probi\u00f3ticos Y Prebi\u00f3ticos Barc."},{"key":"ref_222","unstructured":"Girbal Gonz\u00e1lez, M., Mendes, S., Rodr\u00edguez-Banqueri, A., Eckhard, U., Gomis-R\u00fcth, F.X., Rodr\u00edguez-Lagunas, M.J., Franch, \u00c0., and P\u00e9rez-Cano, F.J. (2025, January 14\u201317). Coeliac Disease Progression Is Preclinically Modulated by Cocoa Intake. Proceedings of the 57th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), Abstract E-books 2025, Helsinki, Finland."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/adc.19.99.99","article-title":"The Treatment of Coeliac Disease with Vitamin B Complex and Concentrated Liver","volume":"19","author":"Paterson","year":"1944","journal-title":"Arch. Dis. Child."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1080\/00365520701881118","article-title":"Homocysteine and Related B-Vitamin Status in Coeliac Disease: Effects of Gluten Exclusion and Histological Recovery","volume":"43","author":"Dickey","year":"2008","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12937-015-0099-8","article-title":"B Vitamins Related to Homocysteine Metabolism in Adults Celiac Disease Patients: A Cross-Sectional Study","volume":"14","author":"Valente","year":"2015","journal-title":"Nutr. J."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12887-018-1107-x","article-title":"Fat Soluble Vitamin Levels in Children with Newly Diagnosed Celiac Disease, a Case Control Study","volume":"18","author":"Terlemez","year":"2018","journal-title":"BMC Pediatr."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s10620-017-4738-0","article-title":"Protective Effect of 1,25-Dihydroxy Vitamin D3 on Pepsin\u2013Trypsin-Resistant Gliadin-Induced Tight Junction Injuries","volume":"63","author":"Dong","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"ref_228","first-page":"711","article-title":"Oral Vitamin E Supplementation in Reducing Nitrosative Stress in Adults Treated for Celiac Disease","volume":"130","author":"Zagrodzki","year":"2020","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Bascu\u00f1\u00e1n, K.A., Araya, M., Rodr\u00edguez, J.M., Roncoroni, L., Elli, L., Alvarez, J.D.P.L., and Valenzuela, R. (2025). Interplay of N-3 Polyunsaturated Fatty Acids, Intestinal Inflammation, and Gut Microbiota in Celiac Disease Pathogenesis. Nutrients, 17.","DOI":"10.3390\/nu17040621"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.clnu.2011.02.007","article-title":"Docosahexaenoic Acid Modulates in Vitro the Inflammation of Celiac Disease in Intestinal Epithelial Cells via the Inhibition of CPLA 2","volume":"30","author":"Vincentini","year":"2011","journal-title":"Clin. Nutr."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"3908675","DOI":"10.1155\/2022\/3908675","article-title":"Aerobic Exercise Associated with Fish Oil Supplementation Decreases C-Reactive Protein and Interleukin-6 in Celiac Disease Patients","volume":"2022","author":"Costa","year":"2022","journal-title":"J. Nutr. Metab."},{"key":"ref_232","first-page":"527","article-title":"Refractory Coeliac Disease; Role of Nigella Sativa as Immunomodulator","volume":"2","author":"Osman","year":"2012","journal-title":"J. Adv. Med. Med. Res."},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Sonzogni, E., Martinelli, G., Fumagalli, M., Maranta, N., Pozzoli, C., Bani, C., Marrari, L.A., Di Lorenzo, C., Sangiovanni, E., and Dell\u2019Agli, M. (2024). In Vitro Insights into the Dietary Role of Glucoraphanin and Its Metabolite Sulforaphane in Celiac Disease. Nutrients, 16.","DOI":"10.3390\/nu16162743"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1080\/10408398.2016.1259209","article-title":"An Emerging Trend in Functional Foods for the Prevention of Cardiovascular Disease and Diabetes: Marine Algal Polyphenols","volume":"58","author":"Murray","year":"2018","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"van der Linde, C., Barone, M., Turroni, S., Brigidi, P., Keleszade, E., Swann, J.R., and Costabile, A. (2021). An in Vitro Pilot Fermentation Study on the Impact of Chlorella Pyrenoidosa on Gut Microbiome Composition and Metabolites in Healthy and Coeliac Subjects. Molecules, 26.","DOI":"10.3390\/molecules26082330"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1002\/fsn3.2344","article-title":"Hydrolytic Enzymes and Their Directly and Indirectly Effects on Gluten and Dough Properties: An Extensive Review","volume":"9","author":"Pourmohammadi","year":"2021","journal-title":"Food Sci. Nutr."},{"key":"ref_237","first-page":"91","article-title":"AN-PEP, Proline-Specific Endopeptidase, Degrades All Known Immunostimulatory Gluten Peptides in Beer Made from Barley Malt","volume":"74","author":"Akeroyd","year":"2016","journal-title":"J. Am. Soc. Brew. Chem."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"337","DOI":"10.52547\/iem.7.4.337","article-title":"Investigating the Effect of Cloned AN-PEP Enzyme in Yeast on Gluten Degradation and Rheological Features of Dough","volume":"7","author":"Hooshiyar","year":"2021","journal-title":"Infect. Epidemiol Microbiol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.lwt.2014.12.010","article-title":"Starch Facilitates Enzymatic Wheat Gluten Hydrolysis","volume":"61","author":"Hardt","year":"2015","journal-title":"LWT"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1002\/jsfa.7515","article-title":"Production of Wheat Gluten Hydrolysates with Reduced Antigenicity Employing Enzymatic Hydrolysis Combined with Downstream Unit Operations","volume":"96","author":"Merz","year":"2016","journal-title":"J. Sci. Food Agric."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/apt.14175","article-title":"Lack of Immunogenicity of Hydrolysed Wheat Flour in Patients with Coeliac Disease after a Short-Term Oral Challenge","volume":"46","author":"Mandile","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1080\/09637486.2019.1599827","article-title":"Effect of PH Control during Rice Fermentation in Preventing a Gliadin P31-43 Entrance in Epithelial Cells","volume":"70","author":"Gallo","year":"2019","journal-title":"Int. J. Food. Sci. Nutr."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"113670","DOI":"10.1016\/j.lwt.2022.113670","article-title":"Novel Insights into Different Kefir Grains Usefulness as Valuable Multiple Starter Cultures to Achieve Bioactive Gluten-Free Sourdoughs","volume":"165","author":"Vasile","year":"2022","journal-title":"LWT"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"100350","DOI":"10.1016\/j.fochx.2022.100350","article-title":"Biological Characteristics of the Gluten-Free Sourdough System Fermented by Lactobacillus Plantarum ST-III and Its Effect on Dough Quality and Nutritional Value during Freezing","volume":"14","author":"Zhou","year":"2022","journal-title":"Food Chem. X"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.foodres.2017.04.025","article-title":"Food Processing and Breeding Strategies for Coeliac-Safe and Healthy Wheat Products","volume":"110","author":"Jouanin","year":"2018","journal-title":"Food Res. Int."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.foodchem.2016.06.043","article-title":"New Insights into Wheat Toxicity: Breeding Did Not Seem to Contribute to a Prevalence of Potential Celiac Disease\u2019s Immunostimulatory Epitopes","volume":"213","author":"Ribeiro","year":"2016","journal-title":"Food Chem."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12870-017-1211-3","article-title":"Production and Molecular Characterization of Bread Wheat Lines with Reduced Amount of \u03b1-Type Gliadins","volume":"17","author":"Camerlengo","year":"2017","journal-title":"BMC Plant Biol."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12870-019-1889-5","article-title":"Outlook for Coeliac Disease Patients: Towards Bread Wheat with Hypoimmunogenic Gluten by Gene Editing of \u03b1- And \u03b3-Gliadin Gene Families","volume":"19","author":"Jouanin","year":"2019","journal-title":"BMC Plant Biol."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3389\/fpls.2018.01523","article-title":"Development of Wheat with Hypoimmunogenic Gluten Obstructed by the Gene Editing Policy in Europe","volume":"9","author":"Jouanin","year":"2018","journal-title":"Front. Plant Sci."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1021\/acs.jafc.4c10318","article-title":"Detoxification Mechanism and the Impact of Transamidation-Modified Gliadin on Celiac-Based Gluten Sensitivity: The Potential of Unlocking Gluten Tolerance in Functional Food","volume":"73","author":"Zhang","year":"2025","journal-title":"J. Agric. Food Chem."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1073\/pnas.1007773107","article-title":"Effective Shutdown in the Expression of Celiac Disease-Related Wheat Gliadin T-Cell Epitopes by RNA Interference","volume":"107","author":"Tollefsen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1053\/j.gastro.2007.06.023","article-title":"Transamidation of Wheat Flour Inhibits the Response to Gliadin of Intestinal T Cells in Celiac Disease","volume":"133","author":"Gianfrani","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"329150","DOI":"10.1155\/2012\/329150","article-title":"Reintroduction of Gluten Following Flour Transamidation in Adult Celiac Patients: A Randomized, Controlled Clinical Study","volume":"2012","author":"Mazzarella","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1039\/C4FO00118D","article-title":"Transamidation of Gluten Proteins during the Bread-Making Process of Wheat Flour to Produce Breads with Less Immunoreactive Gluten","volume":"5","year":"2014","journal-title":"Food Funct."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/ijfs.16945","article-title":"Effects of Transamidation vs. Fermentation to Reduce the Gluten Content of the Triticum Monococcum Wheat Cultivar Hammurabi: Analysis of Biochemical, Baking and Sensory Parameters","volume":"59","author":"Mazzarella","year":"2024","journal-title":"Int. J. Food Sci. Technol."},{"key":"ref_256","unstructured":"Lamacchia, C., Di Luccia, A., and Gianfrani, C. (2015). Method for the Detoxification of Gluten Proteins from Grains of Cereal 2015. (No. 14\/432,461), U.S. Patent Application."},{"key":"ref_257","unstructured":"(2025, July 17). Open Access Government Gluten Friendly Technology Fixes Proteins in Wheat Kernels. Available online: https:\/\/www.openaccessgovernment.org\/gluten-friendly-technology-kernels\/36411\/."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1039\/D1FO00490E","article-title":"Healthy and Pro-Inflammatory Gut Ecology Plays a Crucial Role in the Digestion and Tolerance of a Novel Gluten FriendlyTM Bread in Celiac Subjects: A Randomized, Double Blind, Placebo Control in Vivo Study","volume":"13","author":"Andriulli","year":"2022","journal-title":"Food Funct."},{"key":"ref_259","unstructured":"National Library of Medicine (U.S.) (2025, July 17). In Vivo Effects of the Gluten Friendly Bread in Coeliac Disease, Available online: https:\/\/clinicaltrials.gov\/study\/NCT03168490?intr=gluten%20friendly&rank=1disease."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/18\/2960\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:45:52Z","timestamp":1760035552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/18\/2960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":259,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["nu17182960"],"URL":"https:\/\/doi.org\/10.3390\/nu17182960","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]}}}